AHI Index Sleep Apnoea: Scores and Treatment

The AHI index in sleep apnoea is the key clinical measure used to assess how severely a person's breathing is disrupted during the night. Short for apnoea-hypopnoea index, it counts the average number of breathing interruptions per hour of sleep, combining complete pauses in airflow (apnoeas) and partial reductions (hypopnoeas) into a single score. Understanding your AHI helps clinicians decide whether treatment is needed and which option is most appropriate. This article explains how the AHI is scored, what the results mean for your health, how sleep apnoea is diagnosed and treated on the NHS, and which lifestyle changes may help lower your score.

What is the AHI index and what does it measure in sleep apnoea?

The AHI counts the average number of apnoeas and hypopnoeas per hour of sleep, providing a reproducible measure of OSA severity used in NHS and international clinical guidelines.

The apnoea-hypopnoea index (AHI) is the standard clinical measure used to quantify the severity of obstructive sleep apnoea (OSA) by counting the average number of breathing interruptions per hour of sleep. Each event recorded falls into one of two categories: an apnoea, which is a complete cessation of airflow lasting at least ten seconds, or a hypopnoea, which is a partial reduction in airflow accompanied by a drop in blood oxygen levels or an arousal from sleep.^[3][5] The AHI combines both event types into a single hourly figure, giving clinicians a reproducible way to assess how frequently a person's breathing is disrupted during the night. These definitions are set out in the American Academy of Sleep Medicine (AASM) Scoring Manual and are reflected in NICE guidance (NG202, 2021) and British Thoracic Society (BTS) statements on obstructive sleep apnoea and hypopnoea syndrome (OSAHS).

It is worth noting that scoring rules can vary between services. The AASM permits either a 3% or 4% oxygen desaturation threshold when defining hypopnoeas, and whether arousal alone qualifies an event also differs between protocols.^[4][5] This means AHI values from different laboratories or home-study devices are not always directly comparable.

Many NHS sleep services use home-based limited-channel respiratory studies as the first-line investigation. These devices typically report a Respiratory Event Index (REI) and an Oxygen Desaturation Index (ODI) rather than a full polysomnography-derived AHI, because they cannot confirm sleep onset or measure sleep stages. REI and ODI values may differ from a laboratory AHI, and clinicians take this into account when interpreting results.

Understanding what the AHI captures is important because not all breathing disturbances are equal. Obstructive events occur when the muscles of the upper airway relax and the throat narrows or collapses, temporarily blocking airflow. Central events, by contrast, arise when the brain fails to send the correct signals to the breathing muscles. Most people diagnosed with sleep apnoea have the obstructive form. Where central events predominate, the underlying cause and management differ substantially from OSA, and specialist evaluation is needed. The AHI is the primary metric used in both NHS and international guidelines to guide treatment decisions for OSA.

The AHI is a useful but imperfect tool. Two people with the same AHI score can experience very different symptoms and cardiovascular consequences, depending on factors such as the depth of oxygen desaturation during each event, the duration of events, and individual physiological resilience. Clinicians therefore interpret the AHI alongside symptom burden, daytime sleepiness scores, and oxygen saturation data rather than relying on the number alone.

How is AHI scored and what do the results mean for your health?

An AHI of 5 to 14 indicates mild OSA, 15 to 29 moderate, and 30 or more severe; moderate to severe OSA carries increased risks of hypertension, stroke, and atrial fibrillation.

AHI severity is classified into four bands that directly inform clinical management in adults. A score of fewer than five events per hour is considered normal; five to fourteen events per hour indicates mild OSA; fifteen to twenty-nine events per hour indicates moderate OSA; and thirty or more events per hour indicates severe OSA. These thresholds are used in NHS sleep services and align with NICE guidance (NG202, 2021) and BTS and European Respiratory Society (ERS) statements on OSAHS. It is important to note that these bands apply to adults; paediatric OSA is assessed using different criteria.

The Oxygen Desaturation Index (ODI) measures the number of times per hour that blood oxygen saturation falls by a defined percentage (commonly 3% or 4%) during sleep. Clinicians use the ODI alongside the AHI or REI and the Epworth Sleepiness Scale score to build a complete clinical picture before recommending a treatment pathway.

The health implications of an elevated AHI extend well beyond poor sleep quality. Moderate to severe OSA is associated with an increased risk of hypertension, type 2 diabetes, atrial fibrillation, stroke, and road traffic accidents caused by excessive daytime sleepiness.^[1][2] These associations are recognised in NICE NG202 and BTS and ERS guidance. NICE guidance (NG202, 2021) recommends prompt assessment and treatment for people with moderate or severe disease, as well as for those with mild OSA who have significant symptoms or comorbidities.

For people who are pregnant, untreated OSA is associated with adverse maternal and foetal outcomes.^[12][13] The evidence is largely associative, and anyone with suspected OSA during pregnancy should seek timely referral for assessment. A high AHI alone does not automatically determine treatment; the full clinical context always guides the decision.

How is sleep apnoea diagnosed and treated on the NHS?

NHS diagnosis uses home overnight respiratory studies as first-line investigation, with CPAP recommended for moderate to severe OSA and mandibular advancement devices as an alternative for milder disease.

Sleep apnoea is diagnosed on the NHS through a referral from a GP to a specialist sleep service, where an overnight respiratory study measures breathing patterns, oxygen saturation, airflow, and chest movement. In line with NICE guidance (NG202, 2021) and BTS recommendations, most NHS trusts now offer home sleep studies as the first-line investigation for suspected OSA, reserving in-laboratory polysomnography for complex cases or where a home study is inconclusive. If your GP suspects OSA based on symptoms such as loud snoring, witnessed apnoeas, unrefreshing sleep, or excessive daytime sleepiness, they will typically refer you to a respiratory or sleep medicine clinic for formal assessment.

Treatment depends on AHI severity and symptom burden. For moderate to severe OSA, continuous positive airway pressure (CPAP) therapy is the recommended first-line treatment under NICE guidance (NG202). CPAP delivers a steady stream of pressurised air through a mask worn during sleep, keeping the upper airway open and preventing apnoeic events. Effective CPAP use reduces AHI to near-normal levels and improves daytime alertness. Studies also show that CPAP can reduce blood pressure in people with hypertension, though the reductions are typically modest on average and vary between individuals.^[8][9] For mild OSA, or for people who cannot tolerate CPAP, mandibular advancement devices (MADs) are custom-fitted oral appliances that reposition the lower jaw and are an evidence-based alternative. Access to custom MADs on the NHS depends on local Integrated Care Board (ICB) commissioning decisions and clinical eligibility criteria, so provision varies by region.

NHS availability of sleep services also varies by region, as local ICBs commission services according to local need and resource. If you are waiting for an NHS appointment and your symptoms are significantly affecting your safety, contact your GP promptly.

People diagnosed with OSA or OSAHS who experience excessive daytime sleepiness, or who have moderate to severe OSAHS requiring treatment, have a legal obligation to notify the DVLA and must not drive if they feel sleepy.^[15] Full criteria are set out in the DVLA's guidance document 'Assessing fitness to drive: a guide for medical professionals', which is available on the GOV.UK website. If you drive professionally, discuss your diagnosis with your GP or sleep clinician without delay.

Can lifestyle changes lower your AHI score over time?

Weight loss, alcohol reduction, positional therapy, and smoking cessation can meaningfully reduce AHI, particularly in mild to moderate OSA, but should complement rather than replace prescribed treatment.

Lifestyle changes can meaningfully reduce AHI scores, particularly in people with mild to moderate OSA where excess weight, alcohol use, and sleep position are contributing factors. Weight loss is the most evidence-supported behavioural intervention: adipose tissue around the neck and upper airway narrows the pharyngeal lumen, and studies show that a clinically significant reduction in body weight can lower AHI by a substantial margin in people with obesity-related OSA. NICE guidance (NG202) acknowledges weight management as an important adjunct to device-based treatment, though it is rarely sufficient as a standalone intervention in moderate to severe disease.

Several other lifestyle modifications have supporting evidence:

• Alcohol reduction: Alcohol relaxes upper airway muscles and suppresses arousal responses, worsening both the frequency and duration of apnoeic events. Reducing or eliminating alcohol, particularly in the hours before sleep, can lower AHI.

• Positional therapy: In some people, OSA is predominantly positional, occurring mainly when sleeping on the back (supine). Positional devices or simple measures such as sewing a tennis ball into the back of a pyjama top can encourage side-sleeping and reduce event frequency. Positional therapy is most appropriate for people with confirmed positional OSA; selection should be clinician-led, as adherence can limit effectiveness and not all patients have positional disease.

• Smoking cessation: Smoking causes upper airway inflammation and increases mucus production, both of which worsen OSA. NHS Stop Smoking services offer free support.

• Regular, adequate sleep: Maintaining consistent sleep schedules and avoiding sleep deprivation helps to normalise sleep architecture. Chronic sleep deprivation can worsen OSA severity, partly by increasing the proportion of recovery sleep stages during which muscle tone is reduced.

Lifestyle changes work best as part of a supervised plan alongside medical treatment rather than as a replacement for it. If you have been diagnosed with OSA, discuss any planned changes with your sleep clinician before altering or stopping prescribed therapy. CPAP or a MAD should not be discontinued without clinical advice.

Frequently Asked Questions